Barcelona, Spain, March 8, 2010. - Palau Pharma S.A. ("Palau"), a biopharmaceutical company specialized in developing treatments for patients suffering from inflammatory and autoimmune diseases, announces today the launch of its new website, developed by  Xtranet, an Interactive Production Company. The new website has been designed to enhance usability and provide visitors with quick and easy access to Palau's company and project information. The site has been enriched with new tools, including the offer of downloadable brochures and the free subscription to the latest information about Palau's development projects, corporate information and news.

Palau has also developed its new corporate messages in collaboration with the boutique marketing firm deMaria&Velasco. The statement "Creating Solid Solutions to Existing Needs" summarizes Palau's optimized positioning and will serve as its main message. The concept "Solid" has been chosen to describe the company's philosophy, and is used throughout the website as the main connecting thread.  

Ignacio Faus, CEO at Palau, said: "We are pleased to announce the launch of our new website, which will provide a comprehensive resource for those interested in Palau's projects and capabilities. The term Solid clearly summarizes our strategy, R&D track record and business model. Both website and corporate messages are two key elements towards increasing Palau's visibility in the pharmaceutical, healthcare and investors community, and they will also help position the company as a leading innovator in the European biopharmaceutical industry."

 

About Palau

Palau is a biopharmaceutical company committed to discovering and developing innovative medicines that target the unmet needs of patients suffering from inflammatory and autoimmune diseases, such as asthma, rheumatoid arthritis, ulcerative colitis, and others. Its business strategy consists of developing compounds up to the point of obtaining their proof-of-concept in humans, and then establishing strategic alliances with multinational pharmaceutical companies for their subsequent development and commercialization. Palau commenced operations in November 2006 and its pipeline includes an extensive portfolio of projects, six of which are in clinical Phase. Additionally, Palau has forged important partnerships with internationally renowned companies, including GlaxoSmithKline. Its current investors include Grupo Uriach (majority stakeholder), Caja Duero, Andosins Capital, Caixa Catalunya and Najeti Capital. Further information at www.palaupharma.com.

About deMaria&Velasco

deMaria&Velasco is a boutique consulting firm specializing in branding and positioning for companies in the healthcare sector. Founded by Eva Velasco and Annabel de Maria, two brand managers with extensive experience in the pharmaceutical and biotech industries in both Spain and the US. Their services range from positioning workshops, marketing planning and brand discovery to focused planning and implementation. Further information at www.demariavelasco.com.

About Xtranet

Xtranet is an Interactive Production Company with 10 years experience developing Internet applications. It offers a personalized service in Functional Analysis, Architecture, Structuring, Design, Programming, and a fast and efficient Web maintenance service. Its customized services, together with its internal quality processes and its experienced staff, make up the suitable ingredients to grant Creativity, Technological Reliability and Final Quality: three values that Xtranet applies to all its projects to convey its clients message and strategy efficiently. Further information at www.xtranet.es.